14-80526890-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152446.5(CEP128):c.3051G>T(p.Lys1017Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000499 in 1,603,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152446.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEP128 | NM_152446.5 | c.3051G>T | p.Lys1017Asn | missense_variant | 23/25 | ENST00000555265.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEP128 | ENST00000555265.6 | c.3051G>T | p.Lys1017Asn | missense_variant | 23/25 | 5 | NM_152446.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151506Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250446Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135460
GnomAD4 exome AF: 0.00000413 AC: 6AN: 1452332Hom.: 0 Cov.: 28 AF XY: 0.00000277 AC XY: 2AN XY: 723118
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151506Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73890
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | The c.3051G>T (p.K1017N) alteration is located in exon 22 (coding exon 21) of the CEP128 gene. This alteration results from a G to T substitution at nucleotide position 3051, causing the lysine (K) at amino acid position 1017 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at